Chiral Capsules. 1
J. Am. Chem. Soc., Vol. 120, No. 1, 1998 69
2.95 mg). After 1.5 h of stirring, dibromide 1410 (76.4 mg, 0.148 mmol)
in DMSO (20 ml) was added dropwise, and the mixture was heated
for 1.5 h. The reaction mixture was poured into 1% aqueous HCl.
The mixture was filtered, and the solid was washed with water and
then triturated with MeOH. Subsequent filtration recovered excess
glycolurea as a white solid. The filtrate was evaporated, and the residue
was chromatographed on silica gel with CH2Cl2/AcOEt (3:1) to give
compound 15 (64.1 mg, 51%) as a foam: 1H NMR (300 MHz, CDCl3)
δ 7.06 (d, 2H, J ) 8.4 Hz), 6.95 (d, 2H, J ) 8.4 Hz), 6.65 (d, 2H, J
) 8.4 Hz), 6.55 (d, 2H, J ) 8.4 Hz), 6.17-5.81 (m, 2H), 5.05-4.62
(m, 4H), 4.45-3.99 (m, 4H), 3.81 (t, 2H, J ) 6.7 Hz), 3.76 (t, 2H, J
) 6.7 Hz), 1.73-1.60 (m, 4H), 1.48-1.24 (m, 30H), 0.90-0.82 (m,
molecule complexes of this sort will prove useful for enanti-
oselective recognition; a better environment for such recognition
is hard to imagine. The experience with cyclodextrins does,
however, give cause for concern. The dozens of asymmetric
centers lining their cavities do not often translate into efficient
enantioselection.15 This may be a result of their open-ended
structures or their relatively smooth, rather than bumpy or
cratered interiors. Using calixarene-based capsules, it has
recently been possible to introduce handedness to the lining of
the cavity.16 The clockwise or anticlockwise arrangement of
the series of hydrogen-bonded ureas in these systems emerges
in heterodimers and affects guests accordingly. We will report
on these in due course.17
6H); IR (neat) 3256, 2931, 1708, 1610 1513, 1463, 1248, 1175 cm-1
;
HRMS (FAB, M + Cs+) calcd for C48H64N6O8Cs 985.3840, found
985.3880.
Deprotection. Through a solution of protected hydrazine 15 (713
mg, 0.724 mmol) in CHCl3 (35 ml) was bubbled HCl(g) through a
pipette for 3 min. After 8 h of stirring, the solution was purged with
N2. The solvent was removed in Vacuo, and the material was used in
the next step without further purification: 1H NMR (300 MHz, DMSO-
d6) δ 8.06 (s, 2H), 7.16 (s, 2H), 6.94 (d, 2H, J ) 8.8 Hz), 6.88 (d, 2H,
J ) 9.0 Hz), 6.74 (d, 2H, J ) 8.9 Hz), 6.62 (d, 2H, J ) 8.9 Hz), 4.60
(d, 2H, J ) 15.6 Hz), 4.24-4.00 (m, 4H), 4.03 (d, 2H, J ) 15.6 Hz),
3.86-3.74 (m, 4H), 1.63-1.54 (m, 4H), 1.38-1.19 (m, 12H), 0.86-
0.75 (m, 6H); IR (neat) 3399, 3231, 2931, 1691, 1611, 1511, 1468,
1250, 1178, 835 cm-1; HRMS (FAB, M + Cs+) calcd for C38H48N6O4-
Cs 653.3815, found 653.3845.
Experimental Section
Tetrakis(pentafluorophenyl)ester 7. To a solution of the corre-
sponding tetraacid chloride10 (110 mg, 0.30 mmol), pentafluorophenol
(220 mg, 1.20 mmol), and a catalytic amount of 4-(N,N-dimethylamino)-
pyridine (DMAP) in CH2Cl2 (3 mL) was added Et3N (273 mg, 270
mmol). The mixture was heated under reflux overnight, cooled, washed
with 10% aqueous HCl and water, and then dried over Na2SO4.
Purification of the residue by silica gel column chromatography with
CH2Cl2 as the eluent gave active ester 7 (170 mg, 60%) as a colorless
solid: 1H NMR (300 MHz, CDCl3) δ 4.94 (s, 2H), 2.01 (s, 4H); IR
(neat) 1762, 1652, 1520, 1274, 1208, 1036, 996 cm-1; LRMS (FAB,
M + H+) calcd for C36H7F20O8 947, found 946. The product was
further characterized as its tetra-p-methoxybenzylamide after reaction
with 4 equiv of p-methoxybenzylamine and Et3N in CH2Cl2: HRMS
(FAB, M + Cs+) calcd for C44H46N4O8Cs 891.2370, found 891.2334.
Diesters 10 and 11. To a mixture of the isoamyl hydrazine salt 810
(327 mg, 0.476 mmol) and Et3N (241 mg, 2.38 mmol) in THF (2.5
mL) was quickly added a solution of tetraester 7 (713 mg, 0.713 mmol)
in THF (2 mL). After 10 h of stirring, the solvent was removed.
Chromatography of the residue on silica gel with THF/CHCl3 (3:1)
gave 10 (187 mg, 31 %) and with THF/CHCl3 (1:1) gave the isomer
11 (155 mg, 26 %). Spectroscopic data for 10: 1H NMR (600 MHz,
DMSO-d6) δ 8.08 (s, 2H), 8.07 (s, 2H), 7.79 (s, 2H), 7.48 (s, 2H),
6.95 (d, 2H, J ) 8.8 Hz), 6.89 (d, 2H, J ) 8.8 Hz), 6.74 (d, 2H, J )
8.8 Hz), 6.61 (d, 2H, J ) 8.8 Hz), 5.36 (d, 2H, J ) 15.5 Hz), 5.16 (d,
2H, J ) 15.5 Hz), 4.99 (s, 2H), 4.65 (d, 2H, J ) 15.5 Hz), 4.06 (d,
2H, J ) 15.6 Hz), 3.82 (t, 2H, J ) 6.5 Hz), 3.79 (t, 2H, J ) 6.5 Hz),
1.80-1.74 (m, 2H), 1.65-1.55 (m, 6H), 1.47-1.23 (m, 12H), 0.85 (t,
6H, J ) 6.7 Hz); IR (neat) 3645, 3248, 2957, 2915, 1695, 1629, 1511,
1460, 1230, 1027, 860 cm-1; LRMS (FAB, M + Cs+) calcd 1389;
found 1389.
Softball 1c‚1c. To a suspension of the isoamyl diester 10 (19 mg,
0.017 mmol) and Et3N (8.8 mg, 0.087 mmol) in benzene (2 mL) was
added a solution of hydrazine hydrochloride 9 (12 mg, 0.017 mmol)
in benzene (1.5 mL). After 10 h of stirring, the solvent was removed.
The C-shaped compound (3.2 mg) was obtained by preparative TLC
(eluent CHCl3/AcOEt/MeOH ) 65:25:10). For 1c‚1c: 1H NMR (600
MHz, DMSO-d6) δ 8.45 (s, 2H), 8.04 (s, 2H), 7.44 (s, 2H), 7.42 (s,
2H), 6.93 (d, 2H, J ) 8.7 Hz), 6.88 (d, 2H, J ) 8.7 Hz), 6.73 (d, 2H,
J ) 8.8 Hz), 6.60 (d, 2H, J ) 8.8), 5.29 (d, 2H, J ) 15.7 Hz), 5.24 (d,
2H, J ) 15.7 Hz), 5.09 (d, 2H, J ) 15.7 Hz), 5.08 (d, 2H, J ) 15.7
Hz), 4.97 (s, 2H), 4.63 (d, 2H, J ) 15.7 Hz), 4.60 (d, 2H, J ) 15.7
Hz), 4.45 (d, 2H, J ) 15.7 Hz), 4.18 (t, 2H, J ) 6.8 Hz), 4.05 (t, 2H,
1
J ) 6.8 Hz), 3.82 (d, 2H, J ) 6.4 Hz), 3.79 (t, 2H, J ) 6.4 Hz); H
NMR (600 MHz, C6D6) δ 8.56 (s, 1H), 8.78 (s, 1H), 8.50 (s, 1H), 8.43
(s, 1H), 8.23 (s, 1H), 8.13 (s, 1H), 7.99 (s, 1H), 7.88 (s, 1H), 7.84-
7.80 (m, 2H), 7.08-7.02 (m, 2H), 6.78-6.71 (m, 2H), 6.68-6.62 (m,
2H), 6.59 (d, 1H, J ) 16 Hz), 6.56 (d, 1H, J ) 16 Hz), 6.34 (d, 1H,
J ) 16 Hz), 6.32 (d, 1H, J ) 16 Hz), 5.75 (d, 1H, J ) 16 Hz), 5.73
(d, 1H, J ) 16 Hz), 5.64 (d, 1H, J ) 16 Hz), 5.62 (d, 1H, J ) 16 Hz),
5.62 (s, 1H), 4.61 (s, 1H), 4.52 (d, 1H, J ) 16 Hz), 4.51 (d, 1H, J )
16 Hz), 4.08 (d, 1H, J ) 16 Hz), 4.07 (d, 1H, J ) 16 Hz), 3.85 (d, 1H,
J ) 16 Hz), 3.82 (d, 1H, J ) 16 Hz), 3.67 (d, 1H, J ) 16 Hz), 3.63
(d, 1H, J ) 16 Hz), 3.52-0.81 (4m, 48H); HRMS (FAB, M + Cs+)
calcd for C76H86N12O14Cs 1523.5441, found 1523.5525.
Hydrazine 9 via 15. To a solution of glycolurea 1310 (770 mg,
1.56 mmol) in DMSO (80 ml) at 70 °C was added KOtBu (0.331 mg,
(15) Easton, C. J.; Lincoln, S. F. Chem. Soc. ReV. 1996, 25, 163-170.
(16) Castellano, R. K.; Kim, B. H.; Rebek, J., Jr. Submitted for
publication.
(17) For other systems in which aggregation leads to new chirality, see:
(a) Seto, C. T.; Whitesides, G. M. J. Am. Chem. Soc. 1993, 115, 905-916.
(b) Seto, C. T.; Whitesides, G. M. J. Am. Chem. Soc. 1993, 115, 1330-
1340. (c) Simanek, E. E.; Wazeer, M. I. M.; Mathias, J. P.; Whitesides, G.
M. J. Org. Chem. 1994, 59, 4904-4909. (d) Simanek, E. E.; Qiao, S.; Choi,
I. S.; Whitesides, G. M. J. Org. Chem. 1997, 62, 2619-2621.
Acknowledgment. We are grateful to the National Institutes
of Health and The Skaggs Research Foundation for support of
this work and to Christopher Bayne for preliminary experiments.
JA972885T